Historique
Rapport
HIV prevention, treatment, care and support for people who use stimulant drugs. Technical guide
Auteur(s) :
ONUDC / UNODC (Office des Nations Unies contre la drogue et le crime / United Nations Office on Drugs and Crime) ;
OMS / WHO (Organisation mondiale de la santé / World Health Organization) ;
UNAIDS = ONUSIDA (Joint United Nations Programme on HIV/AIDS)
Année
2019
Page(s) :
76 p.
Sous-type de document :
Guide pratique / Manual
Langue(s) :
Anglais
Éditeur(s) :
Vienna : UNODC
Refs biblio. :
168
Domaine :
Drogues illicites / Illicit drugs
Discipline :
MAL (Maladies infectieuses / Infectious diseases)
Thésaurus mots-clés
VIH
;
HEPATITE
;
PROGRAMME
;
USAGER
;
STIMULANTS
;
PRODUIT ILLICITE
;
TRAITEMENT
;
PREVENTION
;
COCAINE
;
AMPHETAMINE
;
DROGUES DE SYNTHESE
;
INTERVENTION
;
REDUCTION DES RISQUES ET DES DOMMAGES
Thésaurus géographique
INTERNATIONAL
Résumé :
The purpose of this publication is to provide guidance on implementing HIV, hepatitis C (HCV) and hepatitis B (HBV) programmes for people who use stimulant drugs and who are at risk of contracting these viruses. It aims to:
- Increase awareness of the needs and issues faced by the affected groups, including the intersectionality among different key populations;
- Provide implementation guidance to help establish and expand access to core HIV and hepatitis
prevention, treatment, care and support services.
It is a global document that should be adapted according to the specific context, including the type of stimulant drug used (cocaine, ATS or NPS) and the key populations involved, which vary considerably according to regions.
The present guide proposes a package of core interventions adapted from existing international guidance:
- WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users;
- WHO Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations - 2016 update;
- Implementing comprehensive HIV and HCV programmes with people who inject drugs: practical guidance for collaborative interventions (the "IDUIT").
It also incorporates guidance from the implementation tools for other key populations:
- Implementing comprehensive HIV/STI programmes with sex workers: practical approaches from collaborative interventions (the "SWIT");
- Implementing comprehensive HIV and STI programmes with men who have sex with men: practical guidance for collaborative interventions (the "MSMIT");
- Implementing comprehensive HIV and STI programmes with transgender people: practical guidance for collaborative interventions (the "TRANSIT").
However, none of these guidance documents and tools addresses the specific needs of people who use stimulant drugs and are at risk for HIV and hepatitis B and C - hence the need for this publication.
- Increase awareness of the needs and issues faced by the affected groups, including the intersectionality among different key populations;
- Provide implementation guidance to help establish and expand access to core HIV and hepatitis
prevention, treatment, care and support services.
It is a global document that should be adapted according to the specific context, including the type of stimulant drug used (cocaine, ATS or NPS) and the key populations involved, which vary considerably according to regions.
The present guide proposes a package of core interventions adapted from existing international guidance:
- WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users;
- WHO Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations - 2016 update;
- Implementing comprehensive HIV and HCV programmes with people who inject drugs: practical guidance for collaborative interventions (the "IDUIT").
It also incorporates guidance from the implementation tools for other key populations:
- Implementing comprehensive HIV/STI programmes with sex workers: practical approaches from collaborative interventions (the "SWIT");
- Implementing comprehensive HIV and STI programmes with men who have sex with men: practical guidance for collaborative interventions (the "MSMIT");
- Implementing comprehensive HIV and STI programmes with transgender people: practical guidance for collaborative interventions (the "TRANSIT").
However, none of these guidance documents and tools addresses the specific needs of people who use stimulant drugs and are at risk for HIV and hepatitis B and C - hence the need for this publication.